Allarity Therapeutics Inc (ALLR) concluded trading on Tuesday at a closing price of $1.17, with 4.76 million shares of worth about $5.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.01% during that period and on December 31, 2024 the price saw a gain of about 4.46%. Currently the company’s common shares owned by public are about 4.43M shares, out of which, 3.96M shares are available for trading.
Stock saw a price change of 12.50% in past 5 days and over the past one month there was a price change of 6.36%. Year-to-date (YTD), ALLR shares are showing a performance of -99.65% which decreased to -99.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.90 but also hit the highest price of $334.14 during that period. The average intraday trading volume for Allarity Therapeutics Inc shares is 483.96K. The stock is currently trading 10.87% above its 20-day simple moving average (SMA20), while that difference is down -5.77% for SMA50 and it goes to -94.96% lower than SMA200.
Allarity Therapeutics Inc (NASDAQ: ALLR) currently have 4.43M outstanding shares and institutions hold larger chunk of about 0.49% of that.
The stock has a current market capitalization of $5.42M and its 3Y-monthly beta is at 0.23. It has posted earnings per share of -$883.45 in the same period. It has Quick Ratio of 2.75 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALLR, volatility over the week remained 15.04% while standing at 12.36% over the month.
Analysts are in expectations that Allarity Therapeutics Inc (ALLR) stock would likely to be making an EPS of -8.1 in the current quarter, while forecast for next quarter EPS is 0 and it is -46.8 for next year. For the current quarter EPS, analysts have given the company a lowest target -8.1 which is -8.1 at the higher side of the target for the same.
